Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.

Besser, R.; Shields, Beverley; Hammersley, S.; Colclough, Kevin; McDonald, Timothy J.; Gray, Z.; Heywood, J. J. N.; Barrett, T. G.; Hattersley, Andrew T.

URI

http://hdl.handle.net/11287/619081

Author

Besser, R.

Shields, Beverley

Hammersley, S.

Colclough, Kevin

McDonald, Timothy J.

Gray, Z.

Heywood, J. J. N.

Barrett, T. G.

Hattersley, Andrew T.

Date

2013-05

Journal

Pediatric diabetes

Type

Multicenter Study
Research Support, Non-U.S. Gov't

Publisher

Wiley

DOI

10.1111/pedi.12008

Rights

Archived with thanks to Pediatric diabetes

Metadata

Show full item record

Abstract

Making the correct diabetes diagnosis in children is crucial for lifelong management. Type 2 diabetes and maturity onset diabetes of the young (MODY) are seen in the pediatric setting, and can be difficult to discriminate from type 1 diabetes. Postprandial urinary C-peptide creatinine ratio (UCPCR) is a non-invasive measure of endogenous insulin secretion that has not been tested as a diagnostic tool in children or in patients with diabetes duration <5 yr. We aimed to assess whether UCPCR can discriminate type 1 diabetes from MODY and type 2 in pediatric diabetes.

Citation

Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes. 2013, 14 (3):181-8 Pediatr Diabetes

Publisher URL

http://onlinelibrary.wiley.com/doi/10.1111/pedi.12008/abstract

Note

This article is freely available via Open Access. Click on the 'Additional Link' above to access the full-text from the publisher's site.